RASSF Family Proteins and Ras Transformation

Methods in Enzymology

Volumn 407, Issue , 2006, Pages 311-322

  Vos, Michele D ^a   Clark, Geoffrey J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; RAF PROTEIN; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; RAS PROTEIN; TUMOR SUPPRESSOR PROTEIN;

GENETIC CODE; HUMAN; MOLECULAR GENETICS; MULTIGENE FAMILY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; REVIEW;

EID: 33744506550     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(05)07026-6     Document Type: Review

References (26)

1. Agathanggelou A., Cooper W.N., and Latif F. Role of the Ras association domain (RASSF) tumor suppressor genes in human cancer. Cancer Res. 65 (2005) 3497-3508
2. Ahmed-Choudhury J., Agathanggelou A., Fenton S.L., Ricketts C., Clark G.J., Maher E.R., and Latif F. Transcriptional regulation of cyclin A2 by RASSF1A through the enhanced binding of p120E4F to the cyclin A2 promoter. Cancer Res. 65 (2005) 2690-2697
3. Bollag G., and McCormick F. Purification of recombinant Ras GTPase-activating proteins. Methods Enzymol. 255 (1995) 21-30
4. Chen J., Lui W.O., Vos M.D., Clark G.J., Takahashi M., Schoumans J., Khoo S.K., Petillo D., Lavery T., Sugimura J., Astuti D., Zhang C., Kagawa S., Maher E.R., Larsson C., Alberts A.S., Kanayama H.O., and Teh B.T. The t(1;3) breakpoint-spanning genes LSAMP and NORE1 are involved in clear cell renal cell carcinomas. Cancer Cell 4 (2003) 405-413
5. Dallol A., Agathanggelou A., Fenton S.L., Ahmed-Choudhury J., Hesson L., Vos M.D., Clark G.J., Downward J., Maher E.R., and Latif F. RASSF1A interacts with microtubule-associated proteins and modulates microtubule dynamics. Cancer Res. 64 (2004) 4112-4116
6. Denko N.C., Giaccia A.J., Stringer J.R., and Stambrook P.J. The human Ha-ras oncogene induces genomic instability in murine fibroblasts within one cell cycle. Proc. Natl. Acad. Sci. USA 91 (1994) 5124-5128
7. Fiordalisi J.J., Johnson R.L., Ulku A.S., Der C.J., and Cox A.D. Mammalian expression vectors for Ras family proteins: Generation and use of expression constructs to analyze Ras family function. Methods Enzymol. 332 (2001) 3-36
8. Hannon G.J. RNA interference. Nature 418 (2002) 244-251
9. Hannon G.J., and Conklin D.S. RNA interference by short hairpin RNAs expressed in vertebrate cells. Methods Mol. Biol. 257 (2004) 255-266
10. Khokhlatchev A., Rabizadeh S., Xavier R., Nedwidek M., Chen T., Zhang X.F., Seed B., and Avruch J. Identification of a novel Ras-regulated proapoptotic pathway. Curr. Biol. 12 (2002) 253-265
11. Kuzmin I., Gillespie J.W., Protopopov A., Geil L., Dreijerink K., Yang Y., Vocke C.D., Duh F.M., Zabarovsky E., Minna J.D., Rhim J.S., Emmert-Buck M.R., Linehan W.M., and Lerman M.I. The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cells. Cancer Res. 62 (2002) 3498-3502
12. Latif F., and Clark G.J. The RASSF1A/tubulin connection. Cancer Res. Highlights (2004) 6-15
13. Liu L., Tommasi S., Lee D.H., Dammann R., and Pfeifer G.P. Control of microtubule stability by the RASSF1A tumor suppressor. Oncogene 22 (2003) 8125-8136
14. Nechushtan A., Smith C.L., Lamensdorf I., Yoon S.H., and Youle R.J. Bax and Bak coalesce into novel mitochondria-associated clusters during apoptosis. J. Cell Biol. 153 (2001) 1265-1276
15. Paddison P.J., Cleary M., Silva J.M., Chang K., Sheth N., Sachidanandam R., and Hannon G.J. Cloning of short hairpin RNAs for gene knockdown in mammalian cells. Nat. Methods 1 (2004) 163-167
16. Pfeifer G.P., Yoon J.H., Liu L., Tommasi S., Wilczynski S.P., and Dammann R. Methylation of the RASSF1A gene in human cancers. Biol. Chem. 383 (2002) 907-914
17. Rong R., Jin W., Zhang J., Saeed S.M., and Huang Y. Tumor suppressor RASSF1A is a microtubule-binding protein that stabilizes microtubules and induces G2/M arrest. Oncogene 23 (2004) 8216-8230
18. Rubio I., Wittig U., Meyer C., Heinze R., Kadereit D., Waldmann H., Downward J., and Wetzker R. Farnesylation of Ras is important for the interaction with phosphoinositide 3-kinase gamma. Eur. J. Biochem. 266 (1999) 70-82
19. Shivakumar L., Minna J., Sakamaki T., Pestell R., and White M.A. The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol. Cell. Biol. 22 (2001) 4309-4318
20. Thapar R., Williams J.G., and Campbell S.L. NMR characterization of full-length farnesylated and non-farnesylated H-Ras and its implications for Raf activation. J. Mol. Biol. 343 (2004) 1391-1408
21. Tommasi S., Dammann R., Zhang Z., Wang Y., Liu L., Tsark W.M., Wilczynski S.P., Li J., You M., and Pfeifer G.P. Tumor susceptibility of Rassf1a knockout mice. Cancer Res. 65 (2005) 92-98
22. Vavvas D., Li X., Avruch J., and Zhang X.F. Identification of Nore1 as a potential Ras effector. J. Biol. Chem. 273 (1998) 5439-5442
23. Vos M.D., Ellis C.A., Bell A., Birrer M.J., and Clark G.J.R. Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis. J. Biol. Chem. 275 (2000) 35669-35672
24. Vos M.D., Martinez A., Ellis C.A., Vallecorsa T., and Clark G.J. The pro-apoptotic Ras effector Nore1 serves as a Ras-regulated tumor suppressor in the lung. J. Biol. Chem. 278 (2003) 21938-21940
25. Vos M.D., Martinez A., Elam C., Dallol A., Taylor B.J., Latif F., and Clark G.J. A role for the RASSF1A tumor suppressor in the regulation of tubulin polymerization and genomic stability. Cancer Res. 64 (2004) 4244-4250
26. Williams J.G., Drugan J.K., Yi G.S., Clark G.J., Der C.J., and Campbell S.L. Elucidation of binding determinants and functional consequences of Ras/Raf-cysteine-rich domain interactions. J. Biol. Chem. 275 (2000) 22172-22179